HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

testosterone 17 beta-cypionate (Depo-Testosterone)

Subscribe to New Research on testosterone 17 beta-cypionate

Also Known As:

Depo-Testosterone; Andronate; Byk brand of testosterone 17 beta-cypionate; Depo-Testosterone Cypionate; Depostomead; Duratest; Pasadena brand of testosterone 17 beta-cypionate; Pfizer brand of testosterone 17 beta-cypionate; Roberts brand of testosterone 17 beta-cypionate; Spencer Mead brand of testosterone 17 beta-cypionate; Testa-C; Testex Elmu; Vortech brand of testosterone 17 beta-cypionate; deposteron; testosterone 17 beta-cyclopentanepropionate; testosterone 17 beta-cyclopentylpropionate; testosterone cypionate; Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17-beta)-

Networked: 19 relevant articles (0 outcomes, 1 trials/studies)

Drug Context: Research Results

Experts

1.	Henry, L: 2 articles (01/2005 - 01/2004)
2.	Zaid, A: 2 articles (01/2005 - 01/2004)
3.	Aboudkhil, S: 2 articles (01/2005 - 01/2004)
4.	Bureau, J P: 2 articles (01/2005 - 01/2004)
5.	Martinez, Francisco E: 1 article (01/2015)
6.	Fioruci-Fontaneli, Beatriz A: 1 article (01/2015)
7.	Scarano, Wellerson R: 1 article (01/2015)
8.	Anselmo-Franci, Janete A: 1 article (01/2015)
9.	Chuffa, Luiz G A: 1 article (01/2015)
10.	Mendes, Leonardo O: 1 article (01/2015)

Related Diseases

1.	Depressive Disorder (Melancholia) 08/01/2004 - "One hundred twenty-three men with HIV/AIDS with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorder entered the 8-week trial and were randomized to testosterone (up to 400 mg IM testosterone cypionate biweekly), fluoxetine (up to 60 mg/d), or double placebo. "
2.	Acquired Immunodeficiency Syndrome (AIDS) 08/01/2004 - "One hundred twenty-three men with HIV/AIDS with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorder entered the 8-week trial and were randomized to testosterone (up to 400 mg IM testosterone cypionate biweekly), fluoxetine (up to 60 mg/d), or double placebo. "
3.	Neoplasms (Cancer) 01/01/2005 - "Depo-testosterone (DT) injection reduced strongly weight and tumor growth in mice. " 01/01/2004 - "Depo-testosterone (DT) injection reduced strongly weight and tumor growth in mice and DT administration induced a significant increase in the percentage of blood CD8+ cells in grafted mice. " 01/01/2003 - "Depo-testosterone (DT) injection strongly reduced weight and tumor growth in all the intact and castrated animals. " 07/01/1983 - "Hormonal replacement with testosterone cypionate is recommended for pubertal patients undergoing bilateral orchiectomy as a result of tumor removal. "
4.	Body Weight (Weight, Body) 01/01/2012 - "Female Sprague-Dawley rats were divided into 3 groups: the control group(C), n = 10; the andronate-treated group (Andronate), n = 10 (treated with andronate, 1 mg/100 g body weight/day for 8 weeks); and the andronate-treated and high-fat diet group (Andronate+HFD), n = 10. " 09/01/2006 - "Adult females received subcutaneous injections of testosterone cypionate (1 mg/kg body weight every 48 h) up to 21 days. " 09/01/1997 - "Forty HIV-seropositive patients with CD4+ counts of < 2 x 10(5)/l and weight loss greater than 5% of usual body weight were randomized in a double-blind manner to receive 200 mg of testosterone cypionate of placebo intramuscularly every 2 weeks for 3 months. " 01/01/2015 - "At 150 days old, 10 rats from each group received subcutaneous injections of testosterone cypionate (5 mg/kg body weight) diluted in corn oil every other day for 4 weeks, constituting T and EtOH+T, while the remaining animals received corn oil as vehicle. "
5.	Erectile Dysfunction 08/01/1986 - "Chronic testosterone cypionate therapy in men with secondary impotence." 11/01/2002 - "Testoderm-TTS nonscrotal patches and depo-testosterone resulted in significantly higher overall treatment satisfaction (p <.001), confidence in ability to engage in sexual activity (p <.001), and total Erectile Dysfunction Inventory of Treatment Satisfaction and International Index of Erectile Function scores (p <.001). " 11/01/2002 - "Forty-four patients receiving parenteral depo-testosterone, Testoderm scrotal patches, or Testoderm-TTS nonscrotal patches were evaluated with the Erectile Dysfunction Inventory of Treatment Satisfaction and International Index of Erectile Function questionnaires. "

Related Drugs and Biologics

1.	Testosterone (Sustanon)
2.	Fluoxetine (Prozac)
3.	Oxymetholone (Anadrol)
4.	Insulin (Novolin)
5.	Flurazepam (Dalmane)
6.	Fluoxymesterone (Halotestin)
7.	Conjugated (USP) Estrogens (Premarin)
8.	Corn Oil (Oil, Corn)
9.	Blood Glucose (Blood Sugar)

Related Therapies and Procedures

1.	Subcutaneous Injections
2.	Vasectomy (Vas Occlusion)
3.	Palliative Care (Palliative Medicine)
4.	Orchiectomy (Orchidectomy)